Pepijn Burgers

Pepijn Burgers is a principal scientist at Janssen Vaccines and Prevention B.V., located in Leiden, Netherlands. He leads a group of scientists involved in comparability assessments, product characterization, and criticality analyses focused primarily on viral vectors. He previously worked on Janssen’s Ebola vaccine (EMA approval) and more recently was responsible for the product characterization, comparability and control strategies of Janssen’s COVID-19 vaccine candidate. Prior to joining Janssen, he worked at Merck contributing to the successful tech transfers and approval of Keytruda. Pepijn received his B.S. in biology/chemistry from University of New Brunswick (Canada) and M.S. and Ph.D. from Utrecht University (Netherlands).